查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球血漿蛋白治療市場規模、份額和行業趨勢分析報告：按最終用戶、按產品類型（免疫球蛋白、白蛋白、血漿衍生因子 VIII、其他）、按應用、按地區展望和預測，2023-2029 年
市場調查報告書
商品編碼
1276518

全球血漿蛋白治療市場規模、份額和行業趨勢分析報告：按最終用戶、按產品類型（免疫球蛋白、白蛋白、血漿衍生因子 VIII、其他）、按應用、按地區展望和預測，2023-2029 年

Global Plasma Protein Therapeutics Market Size, Share & Industry Trends Analysis Report By End User, By Product Type (Immunoglobulin, Albumin, Plasma derived factor VIII, and Others), By Application, By Regional Outlook and Forecast, 2023 - 2029
出版日期: | 出版商: KBV Research | 英文 231 Pages | 訂單完成後即時交付

價格

到 2029 年，血漿蛋白療法市場規模預計將達到 391 億美元，預計在預測期內將以 5.5% 的複合年增長率增長。

由於人體中的每一種組成蛋白質都有維持體內平衡的特定目的，因此缺少或不足的血漿蛋白質可能是致命的。 已註意到血漿蛋白在許多臨床病理學環境中存在缺陷或功能障礙。 臨床實踐中使用新鮮冷凍血漿 (FFP) 和輸血血漿。

輸血用血漿用於治療一般凝血因子缺乏症，在溶栓治療中糾正纖溶亢進，在血漿置換治療中替代缺乏的因子。 當純化的血漿衍生產品供不應求時，它也是用於分離凝血因子缺陷的方法。 為防止輸血過程中獲得的血源性疾病傳播，採取了供體排除、供體信息、供體篩查、隔離時間和病原體滅活等安全措施。

COVID-19 影響分析

由於許多發達國家這些藥物的短缺，出現了開髮用於控制 COVID-19 的藥物的大好機會。 對 COVID-19 疫苗和藥物不斷增長的需求預示著製藥和生物技術行業的未來增長。 預計這將對血漿蛋白需求產生重大影響。 此外，由於血漿蛋白治療產品的推出和相關研究項目的增加，市場有望擴大。 因此，可以得出結論，大流行對血漿蛋白治療市場產生了有利影響。

市場增長因素

增加創新資金

隨著技術開發出從血漿中分離蛋白質的高效且廉價的方法，血漿蛋白療法市場預計會增長。 由於甲型和乙型肝炎、狂犬病、破傷風和水痘等傳染病的增加，正在進行更多的研究和開發。 此外，還有 200 多種影響免疫和神經系統的危及生命的疾病，包括慢性炎症性脫髓鞘性多發性神經病 (CIDP) 和特發性血小板減少性紫癜。 因此，所有這些因素都將在整個預測期內推動市場的增長。

在治療各種疾病方面對免疫球蛋白的需求不斷增加

Ig 的標籤外使用涉及大量血漿。 IVIG 最常見的超適應症使用實例包括多灶性運動神經病 (MMN)、嬰兒溶血病、急性全神經病、自身免疫性粘膜皮膚大皰病和急性心肌病。 近年來，由於診斷技術的進步和預期壽命的延長，對這些藥物的臨床需求猛增。 預計未來仍將保持增長趨勢。 對 Ig 的需求正在上升，這不僅是由於免疫缺陷，而且是作為治療各種適應症（尤其是某些神經系統疾病）的一部分的慢性超適應症處方。

市場製約因素

報銷問題和嚴格監管導致市場受損的風險

新興國家的血漿採集要求與分餾器不同。 在這些地區，我們遵守關於我們業務質量的嚴格法律和法規，從我們原材料的質量開始。 對於血漿，製造了特定的分餾器。 例如，歐洲衛生當局必須檢查用於分餾的血漿池是否存在細小病毒 B、甲型肝炎、乙型肝炎、丙型肝炎和 HIV。 不幸的是，許多設施的採血操作往往無法滿足這些要求，採集的血漿可能會被浪費。 醫療保健財政的壓力也越來越大。 因此，這些因素可能會阻礙未來幾年的市場擴張。

產品類型展望

按產品類型劃分，血漿蛋白療法市場分為免疫球蛋白、白蛋白、血漿衍生因子 VIII 等。 到 2022 年，免疫球蛋白部分將在血漿蛋白治療市場中佔據最高的收入份額。 該細分市場的增長歸功於免疫球蛋白在治療各種疾病中的使用越來越多。 免疫球蛋白是控制免疫系統並消除細菌和病毒等外來入侵者的蛋白質。 此外，它還用於治療自身免疫性疾病以及原發性和繼發性免疫缺陷。

應用展望

按應用，血漿蛋白治療市場分為血友病、特發性血小板減少性紫癜、原發性免疫缺陷病等。 2022年，原發性免疫缺陷病領域在血漿蛋白治療市場中佔據了重要的收入份額。 原發性免疫缺陷 (PID) 是由免疫系統缺陷引起的 430 多種罕見且長期存在的疾病。 PID 影響全球超過 600 萬人。 因此，預計在預測期內對治療 PID 的血漿蛋白療法的需求將顯著增長。

最終用戶視角

基於最終用戶，血漿蛋白療法市場分為醫院和其他。 2022 年，血漿蛋白治療市場在其他領域出現了顯著增長。 這種增長可歸因於因自身免疫性疾病（如血友病）就診的人數增加以及醫院中蛋白質療法的可用性增加。 由於診所和其他患者護理基礎設施的可負擔性、易於預約以及對患者就診和便利的承諾，它們的使用已經擴大。

區域展望

血漿蛋白治療市場按地區分析，橫跨北美、歐洲、亞太地區和拉美。 北美部分在 2022 年血漿蛋白治療市場中的收入份額最高。 在北美，免疫疾病的患病率正在上升，罕見病的數量在增加，血漿蛋白療法的研究經費也在增加。 此外，製造血漿蛋白療法的大公司的崛起也有助於該地區的市場擴張。 高購買力和成熟的醫療保健系統也是推動市場擴張的因素。

內容

第一章市場範圍與研究方法

  • 市場定義
  • 目的
  • 市場範圍
  • 細分
  • 調查方法

第 2 章市場概述

  • 簡介
    • 概覽
      • 市場構成和情景
  • 影響市場的主要因素
    • 市場驅動因素
    • 市場製約因素

第 3 章競爭分析 - 世界

  • KBV 基數矩陣
  • 近期的全行業戰略發展
    • 夥伴關係、協作和協議
    • 產品發布和產品擴展
    • 收購與合併
    • 地域擴張
    • 批准和試用
  • 關鍵成功策略
    • 主要策略
    • 重大戰略舉措

第 4 章全球血漿蛋白治療市場：按最終用戶分類

  • 全球醫院市場：按地區
  • 按地區劃分的剩餘全球市場

第 5 章全球血漿蛋白治療市場：按產品類型

  • 全球免疫球蛋白市場：按地區
  • 全球白蛋白市場：按地區
  • 全球血漿衍生因子 VIII 市場：按地區
  • 按地區劃分的剩餘全球市場

第 6 章全球血漿蛋白治療市場：按應用

  • 全球血友病市場：按地區
  • 全球特發性血小板減少性紫癜市場：按地區
  • 全球原發性免疫缺陷市場：按地區
  • 按地區劃分的剩餘全球市場

第 7 章全球血漿蛋白治療市場：按地區

  • 北美
    • 北美市場：按國家/地區分類
      • 美國
      • 加拿大
      • 墨西哥
      • 其他北美地區
  • 歐洲
    • 歐洲市場：按國家/地區分類
      • 德國
      • 英國
      • 法國
      • 俄羅斯
      • 西班牙
      • 意大利
      • 其他歐洲地區
  • 亞太地區
    • 亞太市場：按國家/地區分類
      • 中國
      • 日本
      • 印度
      • 韓國
      • 新加坡
      • 馬來西亞
      • 其他亞太地區
  • 拉丁美洲/中東/非洲
    • 按國家/地區劃分的拉丁美洲/中東/非洲市場
      • 巴西
      • 阿根廷
      • 阿拉伯聯合酋長國
      • 沙特阿拉伯
      • 南非
      • 尼日利亞
      • 其他拉丁美洲/中東/非洲地區

第8章公司簡介

  • Bayer AG
  • Grifols, SA
  • Takeda Pharmaceutical Company Limited
  • Kedrion Sp.A
  • ADMA Biologics, Inc
  • Octapharma AG
  • CSL Limited（CSL Behring）
  • Baxter International, Inc
  • Abeona Therapeutics, Inc
  • Taibang Biologic Group

The Global Plasma Protein Therapeutics Market size is expected to reach $39.1 billion by 2029, rising at a market growth of 5.5% CAGR during the forecast period.

Pharmaceuticals known as plasma protein therapeutics are created from proteins extracted from human blood plasma. The biological actions of these proteins include controlling immunological response, blood clotting, and preserving the body's fluid balance. Blood problems, immunological deficiencies, as well as genetic disorders are just a few of the ailments that are treated with plasma protein therapeutics. They are frequently given by injection or infusion, and careful monitoring is necessary to ensure appropriate dosage and reduce any potential side effects.

Plasma is the form of fluid or a part of blood in which cellular components like leucocytes, red blood cells, and platelets are suspended. Plasma makes up 55% of total blood, with 89% of it being water, 2% salt, 3% lipids, and 6% protein. The 2,000-4,000 distinct proteins that make up the plasma proteins (60 g/L) have varying concentrations of hormones as well as about 40 mg/mL (albumin), and their total weight is 60 g/L.

An absence or deficit of a plasma protein could be fatal since each component protein in the human body has a distinct purpose in maintaining homeostasis. Plasma proteins are noted as being absent or dysfunctional in numerous clinical pathological circumstances. In clinical settings, fresh frozen plasma (FFP) or plasma for transfusion both are employed.

Plasma for transfusion is utilized in the treatment of general clotting factor deficiencies as well as in the correction of hyper-fibrinolysis in thrombolysis, replacement of deficient factors during plasmapheresis therapy. The method is also used in isolating deficiencies of clotting factor in lack of purified plasma-derived products. Safety precautions, such as a quarantine time and/or pathogen inactivation, are used in addition to donor exclusion, donor information, and donation screening to avoid the spread of blood-borne illnesses that are transferred during transfusions.

COVID-19 Impact Analysis

Large opportunities for COVID-19 management drug development were offered by the dearth of these medicines in many developed nations. Due to the increasing demand for COVID-19 vaccines and medications, future growth in the pharmaceutical and biotechnology industries is projected. This is expected to have a substantial influence on the demand for plasma protein. In addition, the market is anticipated to expand as a result of more plasma protein therapies product launches and related research projects. Therefore, it can be stated conclusively that the pandemic had a positive impact on the plasma protein therapeutics market.

Market Growth Factors

Growing funding for technological innovation

The market for plasma protein therapeutics is projected to grow due to technological developments in efficient and affordable methods for fractionating proteins from plasma. More R&D is being conducted because of the rising infectious diseases like hepatitis A&B, rabies, tetanus, and varicella. In addition, over 200 life-threatening diseases affect the immune or neurological systems, including chronic inflammatory demyelinating polyneuropathy (CIDP), idiopathic thrombocytopenic purpura. Hence, all these factors will promote the market's growth throughout the forecast period.

Rising need for immunoglobulins for the treatment of various disorders

A significant amount of plasma is used in Ig's widespread off-label usage. Examples of the most prevalent off-label IVIG usage include multifocal motor neuropathy (MMN), infant hemolytic illness, acute panautonomic polyneuropathy, autoimmune mucocutaneous blistering disorders, and acute cardiomyopathy. Due to ongoing advancements in diagnosis and higher life expectancy, the clinical demand for these medications has surged over the past several years. It is predicted to continue on its upward trajectory. The demand for Ig is rising due to immunological inadequacies as well as the chronic usage of off-label prescribing in various indications, especially as part of the treatment of certain neurological diseases.

Market Restraining Factors

Risk of market harm from reimbursement issues and strict regulation

Emerging nations' plasma collection requirements differ from those of fractionators. These areas adhere to stringent laws and norms regarding the caliber of their operations, beginning with the caliber of the raw materials. For plasma, specific fractionators have been created. For instance, the plasma pool used for fractionation must be checked for Parvovirus B, hepatitis A, B, and C, as well as HIV, by the European health authorities. Unfortunately, many facilities' blood collection efforts frequently fail to meet these requirements, wasting some recovered plasma. There is increasing pressure on health finances. Therefore, all these factors may hamper the expansion of the market in the coming years.

Product Type Outlook

Based on product type, the plasma protein therapeutics market is categorized into immunoglobulin, albumin, plasma derived factor VIII, and others. The immunoglobulin segment garnered the highest revenue share in the plasma protein therapeutics market in 2022. The growth of the segment is owed to the rising use of immunoglobulins in treating various diseases. Immunoglobulins are proteins that control the immune system and eliminate foreign invaders like bacteria and viruses. Additionally, it is employed in treating autoimmune diseases and primary and secondary immunodeficiency.

Application Outlook

On the basis of application, the plasma protein therapeutics market is divided into hemophilia, idiopathic thrombocytopenic purpura, primary immunodeficiency disorder, and others. The primary immunodeficiency disorder segment recorded a significant revenue share in the plasma protein therapeutics market in 2022. Primary Immunodeficiency Diseases (PID) are more than 430 uncommon in number, and are long-lasting illnesses brought on by immune system flaws. PID affects over 6.0 million individuals globally. Therefore, the demand for plasma protein therapeutics to treat PID is expected to grow significantly throughout the projection period.

End User Outlook

Based on end user, the plasma protein therapeutics market is segmented into hospitals and others. The others segment garnered a considerable growth rate in the plasma protein therapeutics market in 2022. This growth can be attributed to a rise in the number of people visiting hospitals with autoimmune diseases like hemophilia and the accessibility of protein therapies in hospitals. The use of clinics and other patient care infrastructure has expanded as a result of its affordability, ease of booking appointments, and commitment to patient accessibility and convenience.

Regional Outlook

On the basis of region, the plasma protein therapeutics market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment procured the highest revenue share in the plasma protein therapeutics market in 2022. The prevalence of immunological illnesses is rising, uncommon diseases are becoming more common, and research funding for plasma protein therapies is increasing in North America. Additionally, an increase in the number of major companies producing plasma protein therapies contributes to the market expansion in this region. High purchasing power and the availability of well-established healthcare systems are further factors anticipated to fuel market expansion.

The major strategies followed by the market participants are Acquisitions. Based on the Analysis presented in the Cardinal matrix; CSL Limited (CSL Behring), Baxter International, Inc., Bayer AG, and Takeda Pharmaceutical Company Limited are the forerunners in the Plasma Protein Therapeutics Market. Companies such as Grifols, S.A., Kedrion S.p.A, and ADMA Biologics, Inc. are some of the key innovators in Plasma Protein Therapeutics Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bayer AG, Abeona Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Grifols, S.A., Baxter International, Inc., Kedrion S.p.A, Octapharma AG, CSL Limited (CSL Behring), Taibang Biological Group Co., Ltd and ADMA Biologics, Inc.

Recent Strategies Deployed in Plasma Protein Therapeutics Market

Partnerships, Collaborations and Agreements:

Oct-2022: Takeda partnered with United Nations Institute for Training and Research (UNITAR), a Switzerland headquartered research and training institute. The partnership involves launching the educational program with the intention to create an UN-based platform that would enable stakeholders to gather and discuss solutions related to plasma and plasma-derived therapy shortfalls.

Sep-2022: Grifols entered into an agreement with the National Blood Authority of Canada, a Canadian provider of Blood Services. With this agreement, the entities aimed to accelerate the self-sufficiency of the country in terms of immunoglobulin medicines, which are necessary plasma-protein therapies in order to cure a broad range of immunodeficiencies as well as other medical malignancies.

Feb-2022: Grifols came into collaboration with Endpoint Health, a US-based therapeutics company. The collaboration includes Grifols supporting through its expertise in plasma protein therapies and would act as an exclusive supplier of AT-III. AT-III is a plasma protein that is intended for the treatment of patients with blood clotting. This collaboration reinforces Grifols plasma economics.

Mergers and Acquisitions:

Mar-2023: Takeda took over Nimbus Lakshmi from Nimbus Therapeutics. Nimbus Lakshmi is a US-based developer of medicines for various autoimmune diseases. The addition of Nimbus Lakshmi reinforces Takeda's evolving pipeline and perfectly aligns with its strategy and competence.

Dec-2022: Kedrion acquired UNICAplasma s.r.o and UNICAplasma Morava s.r.o., Czech companies that operate five plasma collection centers in the Czech Republic. The addition of the two Czech-based companies would add significant value to the acquiring company and would further provide Kedrion with high-quality plasma for their production facilities, which in turn would enable the company to develop therapeutics for rare conditions.

Jan-2022: Kedrion formed a merger with Bio Products Laboratory, a company involved in the manufacture of human blood plasma products. Following this merger, the companies aimed to manufacture and develop a strong player within the global plasma derivatives market. Moreover, the new merger would allow the companies to treat patients with hazardous and rare conditions with human blood plasma-derived medicines.

Oct-2202: Kedrion Biopharma took over Prometic, a life sciences business. Through this acquisition, the company aimed to integrate the first-ever FDA-approved Congenital Plasminogen Deficiency treatment medicine of Prometic, Ryplazim. Furthermore, this acquisition would allow Kedrion to expand its footprint throughout North America.

Aug-2021: Bayer acquired Vividion Therapeutics, a US-based developer of a drug discovery platform. The addition of Vividion reinforces the acquiring company's small molecule capabilities and broadens its presence into new modalities. Further, this acquisition acts as a base for Bayer's strategy to power its pipeline with innovation.

Mar-2021: Takeda completed its acquisition of Maverick Therapeutics, a biopharmaceutical company. Under this acquisition, Takeda would leverage the COBRA T-cell engager platform of Maverick to develop more efficient therapies.

Mar-2021: Grifols acquired BPL Plasma, a subsidiary of Bio Products Laboratory. Through this acquisition, the company aimed to reinforce, expand, and diversify its robust network capacity as well as centers in order to deliver life-improving plasma-derived medicines.

Trials and Approvals:

Feb-2023: Octapharma received approval from Europea Medical Authorities for the lyophilized presentation of the well-established octaplasLG, an S/D treated plasma for transfusion. The approved product would be sold in Europe in the form of powder and solvent. The octaplasLG can be reconstituted in a short span of time and can be stored at room temperature. Further, the approval complements the company's commitment to supporting the prevention of uncontrolled hemorrhage.

Feb-2023: FDA approved ADMA's eighth plasma collection center located in Hammond, Louisiana, United States of America. This FDA approval enables the company's eighth collection center to collect, and introduce into interstate commerce, human source plasma. Further, this approval complements the company's aim to be plasma self-sufficient and supports the company in improving its profitability.

Geographical Expansions:

Mar-2023: Takeda expanded its global footprint by setting up a new facility intended for plasma-derived therapies. The new facility is located in Japan. The therapy developing facility reinforces the company's manufacturing and supply capabilities and further enables the company to better take care of the evolving needs for Plasma-Derived Therapies (PDTs) in Japan as well as the rest of the world.

Oct-2022: Grifols established a new manufacturing facility in Ireland. The new facility is established to cater to the evolving needs for plasma-based medicines. The new facility in Ireland triples the company's annual filling production capacity. Further, the geographical expansion demonstrates the company's commitment to investing in plasma medicines infrastructure.

Sep-2022: Takeda expanded its global footprint by setting up a new manufacturing facility in Belgium and expanding its already existing warehouse in Lessines, Belgium. The new facility in Belgium would be equipped with a water recycling system that would reduce freshwater consumption by 90%.

Scope of the Study

Market Segments covered in the Report:

By End User

  • Hospitals
  • Others

By Product Type

  • Immunoglobulin
  • Albumin
  • Plasma derived factor VIII
  • Others

By Application

  • Hemophilia
  • Idiopathic Thrombocytopenic Purpura
  • Primary Immunodeficiency Disorder
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Bayer AG
  • Abeona Therapeutics, Inc.
  • Takeda Pharmaceutical Company Limited
  • Grifols, S.A.
  • Baxter International, Inc.
  • Kedrion S.p.A
  • Octapharma AG
  • CSL Limited (CSL Behring)
  • Taibang Biological Group Co., Ltd
  • ADMA Biologics, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Plasma Protein Therapeutics Market, by End User
    • 1.4.2 Global Plasma Protein Therapeutics Market, by Product Type
    • 1.4.3 Global Plasma Protein Therapeutics Market, by Application
    • 1.4.4 Global Plasma Protein Therapeutics Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition & Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Acquisition and Mergers
    • 3.2.4 Geographical Expansions
    • 3.2.5 Approvals and Trials
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
    • 3.3.2 Key Strategic Move: (Acquisitions and Mergers : 2020, Jun - 2023, Mar) Leading Players

Chapter 4. Global Plasma Protein Therapeutics Market by End User

  • 4.1 Global Hospitals Market by Region
  • 4.2 Global Others Market by Region

Chapter 5. Global Plasma Protein Therapeutics Market by Product Type

  • 5.1 Global Immunoglobulin Market by Region
  • 5.2 Global Albumin Market by Region
  • 5.3 Global Plasma derived factor VIII Market by Region
  • 5.4 Global Others Market by Region

Chapter 6. Global Plasma Protein Therapeutics Market by Application

  • 6.1 Global Hemophilia Market by Region
  • 6.2 Global Idiopathic Thrombocytopenic Purpura Market by Region
  • 6.3 Global Primary Immunodeficiency Disorder Market by Region
  • 6.4 Global Others Market by Region

Chapter 7. Global Plasma Protein Therapeutics Market by Region

  • 7.1 North America Plasma Protein Therapeutics Market
    • 7.1.1 North America Plasma Protein Therapeutics Market by End User
      • 7.1.1.1 North America Hospitals Market by Country
      • 7.1.1.2 North America Others Market by Country
    • 7.1.2 North America Plasma Protein Therapeutics Market by Product Type
      • 7.1.2.1 North America Immunoglobulin Market by Country
      • 7.1.2.2 North America Albumin Market by Country
      • 7.1.2.3 North America Plasma derived factor VIII Market by Country
      • 7.1.2.4 North America Others Market by Country
    • 7.1.3 North America Plasma Protein Therapeutics Market by Application
      • 7.1.3.1 North America Hemophilia Market by Country
      • 7.1.3.2 North America Idiopathic Thrombocytopenic Purpura Market by Country
      • 7.1.3.3 North America Primary Immunodeficiency Disorder Market by Country
      • 7.1.3.4 North America Others Market by Country
    • 7.1.4 North America Plasma Protein Therapeutics Market by Country
      • 7.1.4.1 US Plasma Protein Therapeutics Market
        • 7.1.4.1.1 US Plasma Protein Therapeutics Market by End User
        • 7.1.4.1.2 US Plasma Protein Therapeutics Market by Product Type
        • 7.1.4.1.3 US Plasma Protein Therapeutics Market by Application
      • 7.1.4.2 Canada Plasma Protein Therapeutics Market
        • 7.1.4.2.1 Canada Plasma Protein Therapeutics Market by End User
        • 7.1.4.2.2 Canada Plasma Protein Therapeutics Market by Product Type
        • 7.1.4.2.3 Canada Plasma Protein Therapeutics Market by Application
      • 7.1.4.3 Mexico Plasma Protein Therapeutics Market
        • 7.1.4.3.1 Mexico Plasma Protein Therapeutics Market by End User
        • 7.1.4.3.2 Mexico Plasma Protein Therapeutics Market by Product Type
        • 7.1.4.3.3 Mexico Plasma Protein Therapeutics Market by Application
      • 7.1.4.4 Rest of North America Plasma Protein Therapeutics Market
        • 7.1.4.4.1 Rest of North America Plasma Protein Therapeutics Market by End User
        • 7.1.4.4.2 Rest of North America Plasma Protein Therapeutics Market by Product Type
        • 7.1.4.4.3 Rest of North America Plasma Protein Therapeutics Market by Application
  • 7.2 Europe Plasma Protein Therapeutics Market
    • 7.2.1 Europe Plasma Protein Therapeutics Market by End User
      • 7.2.1.1 Europe Hospitals Market by Country
      • 7.2.1.2 Europe Others Market by Country
    • 7.2.2 Europe Plasma Protein Therapeutics Market by Product Type
      • 7.2.2.1 Europe Immunoglobulin Market by Country
      • 7.2.2.2 Europe Albumin Market by Country
      • 7.2.2.3 Europe Plasma derived factor VIII Market by Country
      • 7.2.2.4 Europe Others Market by Country
    • 7.2.3 Europe Plasma Protein Therapeutics Market by Application
      • 7.2.3.1 Europe Hemophilia Market by Country
      • 7.2.3.2 Europe Idiopathic Thrombocytopenic Purpura Market by Country
      • 7.2.3.3 Europe Primary Immunodeficiency Disorder Market by Country
      • 7.2.3.4 Europe Others Market by Country
    • 7.2.4 Europe Plasma Protein Therapeutics Market by Country
      • 7.2.4.1 Germany Plasma Protein Therapeutics Market
        • 7.2.4.1.1 Germany Plasma Protein Therapeutics Market by End User
        • 7.2.4.1.2 Germany Plasma Protein Therapeutics Market by Product Type
        • 7.2.4.1.3 Germany Plasma Protein Therapeutics Market by Application
      • 7.2.4.2 UK Plasma Protein Therapeutics Market
        • 7.2.4.2.1 UK Plasma Protein Therapeutics Market by End User
        • 7.2.4.2.2 UK Plasma Protein Therapeutics Market by Product Type
        • 7.2.4.2.3 UK Plasma Protein Therapeutics Market by Application
      • 7.2.4.3 France Plasma Protein Therapeutics Market
        • 7.2.4.3.1 France Plasma Protein Therapeutics Market by End User
        • 7.2.4.3.2 France Plasma Protein Therapeutics Market by Product Type
        • 7.2.4.3.3 France Plasma Protein Therapeutics Market by Application
      • 7.2.4.4 Russia Plasma Protein Therapeutics Market
        • 7.2.4.4.1 Russia Plasma Protein Therapeutics Market by End User
        • 7.2.4.4.2 Russia Plasma Protein Therapeutics Market by Product Type
        • 7.2.4.4.3 Russia Plasma Protein Therapeutics Market by Application
      • 7.2.4.5 Spain Plasma Protein Therapeutics Market
        • 7.2.4.5.1 Spain Plasma Protein Therapeutics Market by End User
        • 7.2.4.5.2 Spain Plasma Protein Therapeutics Market by Product Type
        • 7.2.4.5.3 Spain Plasma Protein Therapeutics Market by Application
      • 7.2.4.6 Italy Plasma Protein Therapeutics Market
        • 7.2.4.6.1 Italy Plasma Protein Therapeutics Market by End User
        • 7.2.4.6.2 Italy Plasma Protein Therapeutics Market by Product Type
        • 7.2.4.6.3 Italy Plasma Protein Therapeutics Market by Application
      • 7.2.4.7 Rest of Europe Plasma Protein Therapeutics Market
        • 7.2.4.7.1 Rest of Europe Plasma Protein Therapeutics Market by End User
        • 7.2.4.7.2 Rest of Europe Plasma Protein Therapeutics Market by Product Type
        • 7.2.4.7.3 Rest of Europe Plasma Protein Therapeutics Market by Application
  • 7.3 Asia Pacific Plasma Protein Therapeutics Market
    • 7.3.1 Asia Pacific Plasma Protein Therapeutics Market by End User
      • 7.3.1.1 Asia Pacific Hospitals Market by Country
      • 7.3.1.2 Asia Pacific Others Market by Country
    • 7.3.2 Asia Pacific Plasma Protein Therapeutics Market by Product Type
      • 7.3.2.1 Asia Pacific Immunoglobulin Market by Country
      • 7.3.2.2 Asia Pacific Albumin Market by Country
      • 7.3.2.3 Asia Pacific Plasma derived factor VIII Market by Country
      • 7.3.2.4 Asia Pacific Others Market by Country
    • 7.3.3 Asia Pacific Plasma Protein Therapeutics Market by Application
      • 7.3.3.1 Asia Pacific Hemophilia Market by Country
      • 7.3.3.2 Asia Pacific Idiopathic Thrombocytopenic Purpura Market by Country
      • 7.3.3.3 Asia Pacific Primary Immunodeficiency Disorder Market by Country
      • 7.3.3.4 Asia Pacific Others Market by Country
    • 7.3.4 Asia Pacific Plasma Protein Therapeutics Market by Country
      • 7.3.4.1 China Plasma Protein Therapeutics Market
        • 7.3.4.1.1 China Plasma Protein Therapeutics Market by End User
        • 7.3.4.1.2 China Plasma Protein Therapeutics Market by Product Type
        • 7.3.4.1.3 China Plasma Protein Therapeutics Market by Application
      • 7.3.4.2 Japan Plasma Protein Therapeutics Market
        • 7.3.4.2.1 Japan Plasma Protein Therapeutics Market by End User
        • 7.3.4.2.2 Japan Plasma Protein Therapeutics Market by Product Type
        • 7.3.4.2.3 Japan Plasma Protein Therapeutics Market by Application
      • 7.3.4.3 India Plasma Protein Therapeutics Market
        • 7.3.4.3.1 India Plasma Protein Therapeutics Market by End User
        • 7.3.4.3.2 India Plasma Protein Therapeutics Market by Product Type
        • 7.3.4.3.3 India Plasma Protein Therapeutics Market by Application
      • 7.3.4.4 South Korea Plasma Protein Therapeutics Market
        • 7.3.4.4.1 South Korea Plasma Protein Therapeutics Market by End User
        • 7.3.4.4.2 South Korea Plasma Protein Therapeutics Market by Product Type
        • 7.3.4.4.3 South Korea Plasma Protein Therapeutics Market by Application
      • 7.3.4.5 Singapore Plasma Protein Therapeutics Market
        • 7.3.4.5.1 Singapore Plasma Protein Therapeutics Market by End User
        • 7.3.4.5.2 Singapore Plasma Protein Therapeutics Market by Product Type
        • 7.3.4.5.3 Singapore Plasma Protein Therapeutics Market by Application
      • 7.3.4.6 Malaysia Plasma Protein Therapeutics Market
        • 7.3.4.6.1 Malaysia Plasma Protein Therapeutics Market by End User
        • 7.3.4.6.2 Malaysia Plasma Protein Therapeutics Market by Product Type
        • 7.3.4.6.3 Malaysia Plasma Protein Therapeutics Market by Application
      • 7.3.4.7 Rest of Asia Pacific Plasma Protein Therapeutics Market
        • 7.3.4.7.1 Rest of Asia Pacific Plasma Protein Therapeutics Market by End User
        • 7.3.4.7.2 Rest of Asia Pacific Plasma Protein Therapeutics Market by Product Type
        • 7.3.4.7.3 Rest of Asia Pacific Plasma Protein Therapeutics Market by Application
  • 7.4 LAMEA Plasma Protein Therapeutics Market
    • 7.4.1 LAMEA Plasma Protein Therapeutics Market by End User
      • 7.4.1.1 LAMEA Hospitals Market by Country
      • 7.4.1.2 LAMEA Others Market by Country
    • 7.4.2 LAMEA Plasma Protein Therapeutics Market by Product Type
      • 7.4.2.1 LAMEA Immunoglobulin Market by Country
      • 7.4.2.2 LAMEA Albumin Market by Country
      • 7.4.2.3 LAMEA Plasma derived factor VIII Market by Country
      • 7.4.2.4 LAMEA Others Market by Country
    • 7.4.3 LAMEA Plasma Protein Therapeutics Market by Application
      • 7.4.3.1 LAMEA Hemophilia Market by Country
      • 7.4.3.2 LAMEA Idiopathic Thrombocytopenic Purpura Market by Country
      • 7.4.3.3 LAMEA Primary Immunodeficiency Disorder Market by Country
      • 7.4.3.4 LAMEA Others Market by Country
    • 7.4.4 LAMEA Plasma Protein Therapeutics Market by Country
      • 7.4.4.1 Brazil Plasma Protein Therapeutics Market
        • 7.4.4.1.1 Brazil Plasma Protein Therapeutics Market by End User
        • 7.4.4.1.2 Brazil Plasma Protein Therapeutics Market by Product Type
        • 7.4.4.1.3 Brazil Plasma Protein Therapeutics Market by Application
      • 7.4.4.2 Argentina Plasma Protein Therapeutics Market
        • 7.4.4.2.1 Argentina Plasma Protein Therapeutics Market by End User
        • 7.4.4.2.2 Argentina Plasma Protein Therapeutics Market by Product Type
        • 7.4.4.2.3 Argentina Plasma Protein Therapeutics Market by Application
      • 7.4.4.3 UAE Plasma Protein Therapeutics Market
        • 7.4.4.3.1 UAE Plasma Protein Therapeutics Market by End User
        • 7.4.4.3.2 UAE Plasma Protein Therapeutics Market by Product Type
        • 7.4.4.3.3 UAE Plasma Protein Therapeutics Market by Application
      • 7.4.4.4 Saudi Arabia Plasma Protein Therapeutics Market
        • 7.4.4.4.1 Saudi Arabia Plasma Protein Therapeutics Market by End User
        • 7.4.4.4.2 Saudi Arabia Plasma Protein Therapeutics Market by Product Type
        • 7.4.4.4.3 Saudi Arabia Plasma Protein Therapeutics Market by Application
      • 7.4.4.5 South Africa Plasma Protein Therapeutics Market
        • 7.4.4.5.1 South Africa Plasma Protein Therapeutics Market by End User
        • 7.4.4.5.2 South Africa Plasma Protein Therapeutics Market by Product Type
        • 7.4.4.5.3 South Africa Plasma Protein Therapeutics Market by Application
      • 7.4.4.6 Nigeria Plasma Protein Therapeutics Market
        • 7.4.4.6.1 Nigeria Plasma Protein Therapeutics Market by End User
        • 7.4.4.6.2 Nigeria Plasma Protein Therapeutics Market by Product Type
        • 7.4.4.6.3 Nigeria Plasma Protein Therapeutics Market by Application
      • 7.4.4.7 Rest of LAMEA Plasma Protein Therapeutics Market
        • 7.4.4.7.1 Rest of LAMEA Plasma Protein Therapeutics Market by End User
        • 7.4.4.7.2 Rest of LAMEA Plasma Protein Therapeutics Market by Product Type
        • 7.4.4.7.3 Rest of LAMEA Plasma Protein Therapeutics Market by Application

Chapter 8. Company Profiles

  • 8.1 Bayer AG
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expense
    • 8.1.5 Recent strategies and developments:
      • 8.1.5.1 Partnerships, Collaborations, and Agreements:
      • 8.1.5.2 Acquisition and Mergers:
    • 8.1.6 SWOT Analysis
  • 8.2 Grifols, S.A
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Regional & Segmental Analysis
    • 8.2.4 Research & Development Expenses
    • 8.2.5 Recent strategies and developments:
      • 8.2.5.1 Partnerships, Collaborations, and Agreements:
      • 8.2.5.2 Product Launches and Product Expansions:
      • 8.2.5.3 Acquisition and Mergers:
      • 8.2.5.4 Geographical Expansions:
  • 8.3 Takeda Pharmaceutical Company Limited
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Regional Analysis
    • 8.3.4 Research & Development Expense
    • 8.3.5 Recent strategies and developments:
      • 8.3.5.1 Partnerships, Collaborations, and Agreements:
      • 8.3.5.2 Acquisition and Mergers:
      • 8.3.5.3 Geographical Expansions:
  • 8.4 Kedrion S.p.A
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Research & Development Expenses
    • 8.4.5 Recent strategies and developments:
      • 8.4.5.1 Partnerships, Collaborations, and Agreements:
      • 8.4.5.2 Acquisition and Mergers:
  • 8.5 ADMA Biologics, Inc.
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Segmental and Regional Analysis
    • 8.5.4 Research & Development Expenses
    • 8.5.5 Recent strategies and developments:
      • 8.5.5.1 Approvals and Trials:
  • 8.6 Octapharma AG
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Research & Development Expenses
    • 8.6.4 Recent strategies and developments:
      • 8.6.4.1 Approvals and Trials:
  • 8.7 CSL Limited (CSL Behring)
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Segmental and Regional Analysis
    • 8.7.4 Research & Development Expense
    • 8.7.5 Recent strategies and developments:
      • 8.7.5.1 Acquisition and Mergers:
  • 8.8 Baxter International, Inc.
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Segmental Analysis
    • 8.8.4 Research & Development Expense
  • 8.9 Abeona Therapeutics, Inc.
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Research & Development Expenses
  • 8.10. Taibang Biologic Group
    • 8.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 Global Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 2 Global Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- Plasma Protein Therapeutics Market
  • TABLE 4 Product Launches And Product Expansions- Plasma Protein Therapeutics Market
  • TABLE 5 Acquisition and Mergers- Plasma Protein Therapeutics Market
  • TABLE 6 Geographical expansions - Plasma Protein Therapeutics Market
  • TABLE 7 approvals and trials - Plasma Protein Therapeutics Market
  • TABLE 8 Global Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
  • TABLE 9 Global Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
  • TABLE 10 Global Hospitals Market by Region, 2019 - 2022, USD Million
  • TABLE 11 Global Hospitals Market by Region, 2023 - 2029, USD Million
  • TABLE 12 Global Others Market by Region, 2019 - 2022, USD Million
  • TABLE 13 Global Others Market by Region, 2023 - 2029, USD Million
  • TABLE 14 Global Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
  • TABLE 15 Global Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
  • TABLE 16 Global Immunoglobulin Market by Region, 2019 - 2022, USD Million
  • TABLE 17 Global Immunoglobulin Market by Region, 2023 - 2029, USD Million
  • TABLE 18 Global Albumin Market by Region, 2019 - 2022, USD Million
  • TABLE 19 Global Albumin Market by Region, 2023 - 2029, USD Million
  • TABLE 20 Global Plasma derived factor VIII Market by Region, 2019 - 2022, USD Million
  • TABLE 21 Global Plasma derived factor VIII Market by Region, 2023 - 2029, USD Million
  • TABLE 22 Global Others Market by Region, 2019 - 2022, USD Million
  • TABLE 23 Global Others Market by Region, 2023 - 2029, USD Million
  • TABLE 24 Global Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
  • TABLE 25 Global Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
  • TABLE 26 Global Hemophilia Market by Region, 2019 - 2022, USD Million
  • TABLE 27 Global Hemophilia Market by Region, 2023 - 2029, USD Million
  • TABLE 28 Global Idiopathic Thrombocytopenic Purpura Market by Region, 2019 - 2022, USD Million
  • TABLE 29 Global Idiopathic Thrombocytopenic Purpura Market by Region, 2023 - 2029, USD Million
  • TABLE 30 Global Primary Immunodeficiency Disorder Market by Region, 2019 - 2022, USD Million
  • TABLE 31 Global Primary Immunodeficiency Disorder Market by Region, 2023 - 2029, USD Million
  • TABLE 32 Global Others Market by Region, 2019 - 2022, USD Million
  • TABLE 33 Global Others Market by Region, 2023 - 2029, USD Million
  • TABLE 34 Global Plasma Protein Therapeutics Market by Region, 2019 - 2022, USD Million
  • TABLE 35 Global Plasma Protein Therapeutics Market by Region, 2023 - 2029, USD Million
  • TABLE 36 North America Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 37 North America Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
  • TABLE 38 North America Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
  • TABLE 39 North America Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
  • TABLE 40 North America Hospitals Market by Country, 2019 - 2022, USD Million
  • TABLE 41 North America Hospitals Market by Country, 2023 - 2029, USD Million
  • TABLE 42 North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 43 North America Others Market by Country, 2023 - 2029, USD Million
  • TABLE 44 North America Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
  • TABLE 45 North America Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
  • TABLE 46 North America Immunoglobulin Market by Country, 2019 - 2022, USD Million
  • TABLE 47 North America Immunoglobulin Market by Country, 2023 - 2029, USD Million
  • TABLE 48 North America Albumin Market by Country, 2019 - 2022, USD Million
  • TABLE 49 North America Albumin Market by Country, 2023 - 2029, USD Million
  • TABLE 50 North America Plasma derived factor VIII Market by Country, 2019 - 2022, USD Million
  • TABLE 51 North America Plasma derived factor VIII Market by Country, 2023 - 2029, USD Million
  • TABLE 52 North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 53 North America Others Market by Country, 2023 - 2029, USD Million
  • TABLE 54 North America Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
  • TABLE 55 North America Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
  • TABLE 56 North America Hemophilia Market by Country, 2019 - 2022, USD Million
  • TABLE 57 North America Hemophilia Market by Country, 2023 - 2029, USD Million
  • TABLE 58 North America Idiopathic Thrombocytopenic Purpura Market by Country, 2019 - 2022, USD Million
  • TABLE 59 North America Idiopathic Thrombocytopenic Purpura Market by Country, 2023 - 2029, USD Million
  • TABLE 60 North America Primary Immunodeficiency Disorder Market by Country, 2019 - 2022, USD Million
  • TABLE 61 North America Primary Immunodeficiency Disorder Market by Country, 2023 - 2029, USD Million
  • TABLE 62 North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 63 North America Others Market by Country, 2023 - 2029, USD Million
  • TABLE 64 North America Plasma Protein Therapeutics Market by Country, 2019 - 2022, USD Million
  • TABLE 65 North America Plasma Protein Therapeutics Market by Country, 2023 - 2029, USD Million
  • TABLE 66 US Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 67 US Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
  • TABLE 68 US Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
  • TABLE 69 US Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
  • TABLE 70 US Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
  • TABLE 71 US Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
  • TABLE 72 US Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
  • TABLE 73 US Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
  • TABLE 74 Canada Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 75 Canada Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
  • TABLE 76 Canada Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
  • TABLE 77 Canada Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
  • TABLE 78 Canada Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
  • TABLE 79 Canada Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
  • TABLE 80 Canada Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
  • TABLE 81 Canada Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
  • TABLE 82 Mexico Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 83 Mexico Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
  • TABLE 84 Mexico Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
  • TABLE 85 Mexico Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
  • TABLE 86 Mexico Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
  • TABLE 87 Mexico Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
  • TABLE 88 Mexico Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
  • TABLE 89 Mexico Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
  • TABLE 90 Rest of North America Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 91 Rest of North America Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
  • TABLE 92 Rest of North America Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
  • TABLE 93 Rest of North America Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
  • TABLE 94 Rest of North America Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
  • TABLE 95 Rest of North America Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
  • TABLE 96 Rest of North America Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
  • TABLE 97 Rest of North America Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
  • TABLE 98 Europe Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 99 Europe Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
  • TABLE 100 Europe Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
  • TABLE 101 Europe Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
  • TABLE 102 Europe Hospitals Market by Country, 2019 - 2022, USD Million
  • TABLE 103 Europe Hospitals Market by Country, 2023 - 2029, USD Million
  • TABLE 104 Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 105 Europe Others Market by Country, 2023 - 2029, USD Million
  • TABLE 106 Europe Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
  • TABLE 107 Europe Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
  • TABLE 108 Europe Immunoglobulin Market by Country, 2019 - 2022, USD Million
  • TABLE 109 Europe Immunoglobulin Market by Country, 2023 - 2029, USD Million
  • TABLE 110 Europe Albumin Market by Country, 2019 - 2022, USD Million
  • TABLE 111 Europe Albumin Market by Country, 2023 - 2029, USD Million
  • TABLE 112 Europe Plasma derived factor VIII Market by Country, 2019 - 2022, USD Million
  • TABLE 113 Europe Plasma derived factor VIII Market by Country, 2023 - 2029, USD Million
  • TABLE 114 Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 115 Europe Others Market by Country, 2023 - 2029, USD Million
  • TABLE 116 Europe Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
  • TABLE 117 Europe Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
  • TABLE 118 Europe Hemophilia Market by Country, 2019 - 2022, USD Million
  • TABLE 119 Europe Hemophilia Market by Country, 2023 - 2029, USD Million
  • TABLE 120 Europe Idiopathic Thrombocytopenic Purpura Market by Country, 2019 - 2022, USD Million
  • TABLE 121 Europe Idiopathic Thrombocytopenic Purpura Market by Country, 2023 - 2029, USD Million
  • TABLE 122 Europe Primary Immunodeficiency Disorder Market by Country, 2019 - 2022, USD Million
  • TABLE 123 Europe Primary Immunodeficiency Disorder Market by Country, 2023 - 2029, USD Million
  • TABLE 124 Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 125 Europe Others Market by Country, 2023 - 2029, USD Million
  • TABLE 126 Europe Plasma Protein Therapeutics Market by Country, 2019 - 2022, USD Million
  • TABLE 127 Europe Plasma Protein Therapeutics Market by Country, 2023 - 2029, USD Million
  • TABLE 128 Germany Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 129 Germany Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
  • TABLE 130 Germany Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
  • TABLE 131 Germany Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
  • TABLE 132 Germany Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
  • TABLE 133 Germany Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
  • TABLE 134 Germany Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
  • TABLE 135 Germany Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
  • TABLE 136 UK Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 137 UK Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
  • TABLE 138 UK Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
  • TABLE 139 UK Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
  • TABLE 140 UK Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
  • TABLE 141 UK Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
  • TABLE 142 UK Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
  • TABLE 143 UK Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
  • TABLE 144 France Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 145 France Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
  • TABLE 146 France Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
  • TABLE 147 France Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
  • TABLE 148 France Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
  • TABLE 149 France Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
  • TABLE 150 France Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
  • TABLE 151 France Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
  • TABLE 152 Russia Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 153 Russia Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
  • TABLE 154 Russia Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
  • TABLE 155 Russia Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
  • TABLE 156 Russia Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
  • TABLE 157 Russia Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
  • TABLE 158 Russia Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
  • TABLE 159 Russia Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
  • TABLE 160 Spain Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 161 Spain Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
  • TABLE 162 Spain Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
  • TABLE 163 Spain Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
  • TABLE 164 Spain Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
  • TABLE 165 Spain Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
  • TABLE 166 Spain Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
  • TABLE 167 Spain Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
  • TABLE 168 Italy Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 169 Italy Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
  • TABLE 170 Italy Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
  • TABLE 171 Italy Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
  • TABLE 172 Italy Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
  • TABLE 173 Italy Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
  • TABLE 174 Italy Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
  • TABLE 175 Italy Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
  • TABLE 176 Rest of Europe Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 177 Rest of Europe Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
  • TABLE 178 Rest of Europe Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
  • TABLE 179 Rest of Europe Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
  • TABLE 180 Rest of Europe Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
  • TABLE 181 Rest of Europe Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
  • TABLE 182 Rest of Europe Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
  • TABLE 183 Rest of Europe Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
  • TABLE 184 Asia Pacific Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 185 Asia Pacific Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
  • TABLE 186 Asia Pacific Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
  • TABLE 187 Asia Pacific Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
  • TABLE 188 Asia Pacific Hospitals Market by Country, 2019 - 2022, USD Million
  • TABLE 189 Asia Pacific Hospitals Market by Country, 2023 - 2029, USD Million
  • TABLE 190 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 191 Asia Pacific Others Market by Country, 2023 - 2029, USD Million
  • TABLE 192 Asia Pacific Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
  • TABLE 193 Asia Pacific Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
  • TABLE 194 Asia Pacific Immunoglobulin Market by Country, 2019 - 2022, USD Million
  • TABLE 195 Asia Pacific Immunoglobulin Market by Country, 2023 - 2029, USD Million
  • TABLE 196 Asia Pacific Albumin Market by Country, 2019 - 2022, USD Million
  • TABLE 197 Asia Pacific Albumin Market by Country, 2023 - 2029, USD Million
  • TABLE 198 Asia Pacific Plasma derived factor VIII Market by Country, 2019 - 2022, USD Million
  • TABLE 199 Asia Pacific Plasma derived factor VIII Market by Country, 2023 - 2029, USD Million
  • TABLE 200 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 201 Asia Pacific Others Market by Country, 2023 - 2029, USD Million
  • TABLE 202 Asia Pacific Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
  • TABLE 203 Asia Pacific Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
  • TABLE 204 Asia Pacific Hemophilia Market by Country, 2019 - 2022, USD Million
  • TABLE 205 Asia Pacific Hemophilia Market by Country, 2023 - 2029, USD Million
  • TABLE 206 Asia Pacific Idiopathic Thrombocytopenic Purpura Market by Country, 2019 - 2022, USD Million
  • TABLE 207 Asia Pacific Idiopathic Thrombocytopenic Purpura Market by Country, 2023 - 2029, USD Million
  • TABLE 208 Asia Pacific Primary Immunodeficiency Disorder Market by Country, 2019 - 2022, USD Million
  • TABLE 209 Asia Pacific Primary Immunodeficiency Disorder Market by Country, 2023 - 2029, USD Million
  • TABLE 210 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 211 Asia Pacific Others Market by Country, 2023 - 2029, USD Million
  • TABLE 212 Asia Pacific Plasma Protein Therapeutics Market by Country, 2019 - 2022, USD Million
  • TABLE 213 Asia Pacific Plasma Protein Therapeutics Market by Country, 2023 - 2029, USD Million
  • TABLE 214 China Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 215 China Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
  • TABLE 216 China Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
  • TABLE 217 China Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
  • TABLE 218 China Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
  • TABLE 219 China Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
  • TABLE 220 China Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
  • TABLE 221 China Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
  • TABLE 222 Japan Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 223 Japan Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
  • TABLE 224 Japan Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
  • TABLE 225 Japan Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
  • TABLE 226 Japan Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
  • TABLE 227 Japan Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
  • TABLE 228 Japan Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
  • TABLE 229 Japan Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
  • TABLE 230 India Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 231 India Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
  • TABLE 232 India Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
  • TABLE 233 India Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
  • TABLE 234 India Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
  • TABLE 235 India Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
  • TABLE 236 India Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
  • TABLE 237 India Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
  • TABLE 238 South Korea Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 239 South Korea Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
  • TABLE 240 South Korea Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
  • TABLE 241 South Korea Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
  • TABLE 242 South Korea Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
  • TABLE 243 South Korea Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
  • TABLE 244 South Korea Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
  • TABLE 245 South Korea Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
  • TABLE 246 Singapore Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 247 Singapore Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
  • TABLE 248 Singapore Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
  • TABLE 249 Singapore Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
  • TABLE 250 Singapore Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
  • TABLE 251 Singapore Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
  • TABLE 252 Singapore Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
  • TABLE 253 Singapore Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
  • TABLE 254 Malaysia Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 255 Malaysia Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
  • TABLE 256 Malaysia Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
  • TABLE 257 Malaysia Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
  • TABLE 258 Malaysia Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
  • TABLE 259 Malaysia Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
  • TABLE 260 Malaysia Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
  • TABLE 261 Malaysia Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
  • TABLE 262 Rest of Asia Pacific Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 263 Rest of Asia Pacific Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
  • TABLE 264 Rest of Asia Pacific Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
  • TABLE 265 Rest of Asia Pacific Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
  • TABLE 266 Rest of Asia Pacific Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
  • TABLE 267 Rest of Asia Pacific Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
  • TABLE 268 Rest of Asia Pacific Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
  • TABLE 269 Rest of Asia Pacific Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
  • TABLE 270 LAMEA Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 271 LAMEA Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
  • TABLE 272 LAMEA Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
  • TABLE 273 LAMEA Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
  • TABLE 274 LAMEA Hospitals Market by Country, 2019 - 2022, USD Million
  • TABLE 275 LAMEA Hospitals Market by Country, 2023 - 2029, USD Million
  • TABLE 276 LAMEA Others Market by Country, 2019 - 2022, USD Million
  • TABLE 277 LAMEA Others Market by Country, 2023 - 2029, USD Million
  • TABLE 278 LAMEA Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
  • TABLE 279 LAMEA Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
  • TABLE 280 LAMEA Immunoglobulin Market by Country, 2019 - 2022, USD Million
  • TABLE 281 LAMEA Immunoglobulin Market by Country, 2023 - 2029, USD Million
  • TABLE 282 LAMEA Albumin Market by Country, 2019 - 2022, USD Million
  • TABLE 283 LAMEA Albumin Market by Country, 2023 - 2029, USD Million
  • TABLE 284 LAMEA Plasma derived factor VIII Market by Country, 2019 - 2022, USD Million
  • TABLE 285 LAMEA Plasma derived factor VIII Market by Country, 2023 - 2029, USD Million
  • TABLE 286 LAMEA Others Market by Country, 2019 - 2022, USD Million
  • TABLE 287 LAMEA Others Market by Country, 2023 - 2029, USD Million
  • TABLE 288 LAMEA Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
  • TABLE 289 LAMEA Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
  • TABLE 290 LAMEA Hemophilia Market by Country, 2019 - 2022, USD Million
  • TABLE 291 LAMEA Hemophilia Market by Country, 2023 - 2029, USD Million
  • TABLE 292 LAMEA Idiopathic Thrombocytopenic Purpura Market by Country, 2019 - 2022, USD Million
  • TABLE 293 LAMEA Idiopathic Thrombocytopenic Purpura Market by Country, 2023 - 2029, USD Million
  • TABLE 294 LAMEA Primary Immunodeficiency Disorder Market by Country, 2019 - 2022, USD Million
  • TABLE 295 LAMEA Primary Immunodeficiency Disorder Market by Country, 2023 - 2029, USD Million
  • TABLE 296 LAMEA Others Market by Country, 2019 - 2022, USD Million
  • TABLE 297 LAMEA Others Market by Country, 2023 - 2029, USD Million
  • TABLE 298 LAMEA Plasma Protein Therapeutics Market by Country, 2019 - 2022, USD Million
  • TABLE 299 LAMEA Plasma Protein Therapeutics Market by Country, 2023 - 2029, USD Million
  • TABLE 300 Brazil Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 301 Brazil Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
  • TABLE 302 Brazil Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
  • TABLE 303 Brazil Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
  • TABLE 304 Brazil Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
  • TABLE 305 Brazil Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
  • TABLE 306 Brazil Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
  • TABLE 307 Brazil Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
  • TABLE 308 Argentina Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 309 Argentina Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
  • TABLE 310 Argentina Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
  • TABLE 311 Argentina Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
  • TABLE 312 Argentina Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
  • TABLE 313 Argentina Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
  • TABLE 314 Argentina Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
  • TABLE 315 Argentina Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
  • TABLE 316 UAE Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 317 UAE Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
  • TABLE 318 UAE Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
  • TABLE 319 UAE Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
  • TABLE 320 UAE Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
  • TABLE 321 UAE Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
  • TABLE 322 UAE Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
  • TABLE 323 UAE Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
  • TABLE 324 Saudi Arabia Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 325 Saudi Arabia Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
  • TABLE 326 Saudi Arabia Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
  • TABLE 327 Saudi Arabia Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
  • TABLE 328 Saudi Arabia Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
  • TABLE 329 Saudi Arabia Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
  • TABLE 330 Saudi Arabia Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
  • TABLE 331 Saudi Arabia Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
  • TABLE 332 South Africa Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 333 South Africa Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
  • TABLE 334 South Africa Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
  • TABLE 335 South Africa Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
  • TABLE 336 South Africa Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
  • TABLE 337 South Africa Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
  • TABLE 338 South Africa Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
  • TABLE 339 South Africa Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
  • TABLE 340 Nigeria Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 341 Nigeria Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
  • TABLE 342 Nigeria Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
  • TABLE 343 Nigeria Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
  • TABLE 344 Nigeria Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
  • TABLE 345 Nigeria Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
  • TABLE 346 Nigeria Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
  • TABLE 347 Nigeria Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
  • TABLE 348 Rest of LAMEA Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 349 Rest of LAMEA Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
  • TABLE 350 Rest of LAMEA Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
  • TABLE 351 Rest of LAMEA Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
  • TABLE 352 Rest of LAMEA Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
  • TABLE 353 Rest of LAMEA Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
  • TABLE 354 Rest of LAMEA Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
  • TABLE 355 Rest of LAMEA Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
  • TABLE 356 Key Information - Bayer AG
  • TABLE 357 Key information - Grifols, S.A.
  • TABLE 358 Key Information - Takeda Pharmaceutical Company Limited
  • TABLE 359 key Information - Kedrion S.p.A
  • TABLE 360 Key Information - ADMA Biologics, Inc.
  • TABLE 361 Key Information - Octapharma AG
  • TABLE 362 key Information - CSL Limited
  • TABLE 363 Key Information - Baxter International, Inc.
  • TABLE 364 Key Information - Abeona Therapeutics, Inc.
  • TABLE 365 Key Information - Taibang Biologic Group

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
  • FIG 4 Key Strategic Move: (Acquisitions and Mergers : 2020, Jun - 2023, Mar) Leading Players
  • FIG 5 Global Plasma Protein Therapeutics Market share, by End User, 2022
  • FIG 6 Global Plasma Protein Therapeutics Market share, by End User, 2029
  • FIG 7 Global Plasma Protein Therapeutics Market by End User, 2019 - 2029, USD Million
  • FIG 8 Global Plasma Protein Therapeutics Market share, by Product Type, 2022
  • FIG 9 Global Plasma Protein Therapeutics Market share, by Product Type, 2029
  • FIG 10 Global Plasma Protein Therapeutics Market by Product Type, 2019 - 2029, USD Million
  • FIG 11 Global Plasma Protein Therapeutics Market share by Application, 2022
  • FIG 12 Global Plasma Protein Therapeutics Market share by Application, 2029
  • FIG 13 Global Plasma Protein Therapeutics Market by Application, 2019 - 2029, USD Million
  • FIG 14 Global Plasma Protein Therapeutics Market share, by Region, 2022
  • FIG 15 Global Plasma Protein Therapeutics Market share, by Region, 2029
  • FIG 16 Global Plasma Protein Therapeutics Market by Region, 2019 - 2029, USD Million
  • FIG 17 Swot analysis: bayer ag
  • FIG 18 Recent strategies and developments: Grifols, S.A.
  • FIG 19 Recent strategies and developments: Takeda Pharmaceutical Company Limited
  • FIG 20 Recent strategies and developments: Kedrion S.p.A